Compounds > pd 98059

pd 98059 and pituitrin

pd 98059 has been researched along with pituitrin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ito, H; Ito, T; Kato, K; Kozawa, O; Matsuno, H; Niwa, M; Sakai, N; Tanabe, K; Uematsu, T1
Christoffersen, T; Hege Thoresen, G; Nilssen, LS; Sandnes, D1
Christoffels, VM; Hoogaars, WM; Peters, SL; Pfaffendorf, M; Sand, C; Streefkerk, JO; Van Zwieten, PA1
Doucet, A; Firsov, D; Horisberger, JD; Mercier, A; Michlig, S; Rossier, BC; Schild, L1
Bhattacharya, B; Latif, ML; Roberts, RE; Williams, R1

Other Studies

5 other study(ies) available for pd 98059 and pituitrin

ArticleYear
p38 MAP kinase is required for vasopressin-stimulated HSP27 induction in aortic smooth muscle cells.
    Hypertension (Dallas, Tex. : 1979), 2000, Volume: 35, Issue:2

    Topics: Animals; Aorta; Arginine Vasopressin; Cell Line; Enzyme Inhibitors; Flavonoids; Gene Expression Regulation; Imidazoles; Immunoassay; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Naphthalenes; Neoplasm Proteins; p38 Mitogen-Activated Protein Kinases; Phospholipid Ethers; Phosphorylation; Protein Kinase C; Pyridines; RNA, Messenger; Tetradecanoylphorbol Acetate; Vasopressins

2000
Differential role of MAP kinases in stimulation of hepatocyte growth by EGF and G-protein-coupled receptor agonists.
    Biochemical and biophysical research communications, 2002, Mar-01, Volume: 291, Issue:3

    Topics: Angiotensin II; Animals; Cell Division; Dinoprost; DNA; Enzyme Inhibitors; Epidermal Growth Factor; Flavonoids; Hepatocytes; Heterotrimeric GTP-Binding Proteins; Imidazoles; Male; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Norepinephrine; p38 Mitogen-Activated Protein Kinases; Pyridines; Rats; Rats, Wistar; Receptors, Cell Surface; Vasopressins

2002
Vasopressin-induced vasoconstriction is dependent on MAPKerk1/2 phosphorylation.
    Fundamental & clinical pharmacology, 2004, Volume: 18, Issue:1

    Topics: Animals; Aorta, Thoracic; Blotting, Western; Butadienes; Enzyme Inhibitors; Flavonoids; In Vitro Techniques; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Muscle Contraction; Muscle, Smooth, Vascular; Myocardial Contraction; Nitriles; Phosphorylation; Potassium; Rats; Rats, Wistar; Signal Transduction; Vasoconstrictor Agents; Vasopressins

2004
ERK1/2 controls Na,K-ATPase activity and transepithelial sodium transport in the principal cell of the cortical collecting duct of the mouse kidney.
    The Journal of biological chemistry, 2004, Dec-03, Volume: 279, Issue:49

    Topics: Aldosterone; Animals; Biological Transport; Biotinylation; Blotting, Western; Cell Membrane; Cells, Cultured; Dose-Response Relationship, Drug; Electrophysiology; Enzyme Inhibitors; Flavonoids; Kidney; Kidney Tubules, Collecting; Ligands; Male; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Nephrons; Phosphorylation; Sodium; Sodium-Potassium-Exchanging ATPase; Time Factors; Up-Regulation; Vasopressins

2004
Role of cytosolic phospholipase A2 in the enhancement of alpha2-adrenoceptor-mediated vasoconstriction by the thromboxane-mimetic U46619 in the porcine isolated ear artery: comparison with vasopressin-enhanced responses.
    Biochemical pharmacology, 2005, Oct-15, Volume: 70, Issue:8

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blotting, Western; Cytosol; Enzyme Inhibitors; Flavonoids; Phospholipases A; Phospholipases A2; Receptors, Adrenergic, alpha-2; Swine; Vasoconstrictor Agents; Vasopressins

2005